DOI: 10.25881/20728255_2021_16_3_125

Authors

Solovyov I.A.1, Pershko A.M.2, Vasilchenko M.V.2, Gravshina E.N.2, Kazimagomedov K.N.2, Lychev A.B.2, Grebenkov V.G.2

1 Mariinsky Hospital, St. Petersburg

2 S.M. Kirov Military medical academy, St. Petersburg

Abstract

Currently, antibiotic therapy is of leading importance in the prevention of complications after operations on the abdominal organs. With prolonged use, antibiotic-associated diarrhea may develop, which in 80–90% is idiopathic in nature and independently passes after the withdrawal of antibiotics. 10–20% of patients develop pseudomembranous colitis caused by C. difficile and present a serious problem for the health of patients, up to a fatal outcome 13–38%. The article presents a case of successful treatment of pseudomembranous colitis in a 70-year-old patient after laparoscopic abdominal-anal rectal resection, performed for cancer of the lower and middle ampullary rectum рT3N0M0G1.

Keywords: rectal cancer, pseudomembranous colitis, antibiotic-associated diarrhea, abdominal-anal resection of the rectum.

References

1. Ivashkin VT, Shelygin UA, Halif IL, et al. Rekomendacii Rossijskoj gastroenterologicheskoj associacii i Associacii koloproktologov Rossii po diagnostike i lecheniyu vzroslyh bol’nyh yazvennym kolitom. Rossijskij zhurnal gastroenterologii, gepatologii, koloproktologii. 2015; 25(1): 48-65. (In Russ).

2. Ivashkin VT, Shelygin UA, Abdulganieva DI, et al. Proekt klinicheskih rekomendacij po diagnostike i lecheniyu vzroslyh pacientov s bolezn’yu Krona. Koloproktologiya. 2013; S3(45): 4-21. (In Russ).

3. Korneeva ON, Ivashkin VT. Antibiotikoassociirovannyj kolit: patomorfologiya, klinika, lechenie. Rossijskij zhurnal gastroenterologii, gepatologii, koloproktologii. 2007; 17(3): 65-71. (In Russ).

4. Lau CS, Chamberlain RS. Probiotics are effective at preventing Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Int J Gen Med. 2016; 9: 27-37. doi:10.2147/IJGM.S98280.

5. Lobzin UV, Zaharenko SM, Ivanov GA, et al. Sovremennye predstavleniya ob infekcii Clostridium difficile. Klinicheskaya mikrobiologiya i antimikrobnaya himioterapiya. 2002; 4(3): 200-232. (In Russ).

6. Ivashkin V.T., Ivashkina N.YU., Baranskaya E.K. Racional'naya farmakoterapiya zabolevanij organov pishchevareniya: rukovodstvo dlya praktikuyushchih vrachej. Moskva: Litterra, 2007.

7. Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014; 146(6): 1489-1499. doi:10.1053/j.gastro.2014.02.009.

8. Safin AL, Achkasov SI, Suhina MA. Faktory riska razvitiya diarei, associirovannoj s Slostridium difficile, u koloproktologicheskih bol’nyh (obzor literatury). Koloproktologiya. 2017; 1(59): 59-67. (In Russ).

9. Sheptulin AA. Refrakternye i recidiviruyushchie formy kolita, associirovannogo s Clostridium difficile. Rossijskij zhurnal gastroenterologii, gepatologii i koloproktologii. 2011; 2: 50-53. (In Russ).

10. Shelygin UA, Aleshkin VA, Suhina MA, et al. Klinicheskie rekomendacii nacional’noj associacii specialistov po kontrolyu infekcij, svyazannyh s okazaniem medicinskoj pomoshchi i obshcherossijskoj obshchestvennoj nekommercheskoj organizacii «associacii koloproktologov rossii» po diagnostike, lecheniyu i profilaktike clostridium difficile-associirovannoj diarei (CDI). Koloproktologiya. 2018; 65(3): 7-21. (In Russ).

11. Collins DA, Elliott B, Riley TV. Molecular methods for detecting and typing of Clostridium difficile. Pathology. 2015; 47(3): 211-218. doi: 10.1097/PAT.0000000000000238.

12. Knight DR, Elliott B, Chang BJ, Perkins TT, Riley TV. Diversity and Evolution in the Genome of Clostridium difficile. Clin Microbiol Rev. 2015; 28(3): 721-741. doi: 10.1128/CMR. 00127-14.

13. Steindl G, Fiedler A, Huhulescu S, Wewalka G, Allerberger F. Effect of airborne hydrogen peroxide on spores of Clostridium difficile. Wien Klin Wochenschr. 2015; 127(11-12): 421-426. doi: 10.1007/s00508-014-0682-6.

14. Surawicz CM, Brandt LJ, Binion DG, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013; 108(4): 478-499. doi: 10.1038/ajg.2013.4.

15. Wright Donna F.R. Largest ever European clinician consensus report on Clostridium difficile infection provides recommendations for improved management of CDI pressemitteilung astellas. EMEA. 2014.

16. Yoon SS, Kim EK, Lee WJ. Functional genomic and metagenomic approaches to understanding gut microbiota-animal mutualism. Curr Opin Microbiol. 2015; 24: 38-46. doi:10.1016/j.mib.2015.01.007.

For citation

Solovyov I.A., Pershko A.M., Vasilchenko M.V., Gravshina E.N., Kazimagomedov K.N., Lychev A.B., Grebenkov V.G. A clinical case of successful treatment of pseudomembranous colitis in the practice of a surgeon. Bulletin of Pirogov National Medical & Surgical Center. 2021;3(16):125-129. (In Russ.) https://doi.org/10.25881/20728255_2021_16_3_125